TY - JOUR
T1 - Endoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryo
AU - Nomura-Kitabayashi, Aya
AU - Anderson, Gregory A.
AU - Sleep, Gillian
AU - Mena, Jenny
AU - Karabegovic, Amna
AU - Karamath, Sharon
AU - Letarte, Michelle
AU - Puri, Mira C.
N1 - Funding Information:
The authors thank Drs. Janet Rossant and Hiroki Kokubo for in situ probes, Petia Stefanova for histology, and Drs. Aly Karsan and Jorge Filmus for comments on the manuscript. Funding for this work was provided by the Heart and Stroke Foundation of Canada (grants NA-5427 and T5598).
PY - 2009/11/1
Y1 - 2009/11/1
N2 - Vascular patterning depends on precisely coordinated timing of endothelial cell differentiation and onset of cardiac function. Endoglin is a transmembrane receptor for members of the TGF-β superfamily that is expressed on endothelial cells from early embryonic gestation to adult life. Heterozygous loss of function mutations in human ENDOGLIN cause Hereditary Hemorrhagic Telangiectasia Type 1, a vascular disorder characterized by arteriovenous malformations that lead to hemorrhage and stroke. Endoglin null mice die in embryogenesis with numerous lesions in the cardiovascular tree including incomplete yolk sac vessel branching and remodeling, vessel dilation, hemorrhage and abnormal cardiac morphogenesis. Since defects in multiple cardiovascular tissues confound interpretations of these observations, we performed in vivo chimeric rescue analysis using Endoglin null embryonic stem cells. We demonstrate that Endoglin is required cell autonomously for endocardial to mesenchymal transition during formation of the endocardial cushions. Endoglin null cells contribute widely to endothelium in chimeric embryos rescued from cardiac development defects, indicating that Endoglin is dispensable for angiogenesis and vascular remodeling in the midgestation embryo, but is required for early patterning of the heart.
AB - Vascular patterning depends on precisely coordinated timing of endothelial cell differentiation and onset of cardiac function. Endoglin is a transmembrane receptor for members of the TGF-β superfamily that is expressed on endothelial cells from early embryonic gestation to adult life. Heterozygous loss of function mutations in human ENDOGLIN cause Hereditary Hemorrhagic Telangiectasia Type 1, a vascular disorder characterized by arteriovenous malformations that lead to hemorrhage and stroke. Endoglin null mice die in embryogenesis with numerous lesions in the cardiovascular tree including incomplete yolk sac vessel branching and remodeling, vessel dilation, hemorrhage and abnormal cardiac morphogenesis. Since defects in multiple cardiovascular tissues confound interpretations of these observations, we performed in vivo chimeric rescue analysis using Endoglin null embryonic stem cells. We demonstrate that Endoglin is required cell autonomously for endocardial to mesenchymal transition during formation of the endocardial cushions. Endoglin null cells contribute widely to endothelium in chimeric embryos rescued from cardiac development defects, indicating that Endoglin is dispensable for angiogenesis and vascular remodeling in the midgestation embryo, but is required for early patterning of the heart.
KW - Angiogenesis
KW - Atrioventricular canal
KW - Endocardial-to-mesenchymal transition
KW - Endoglin
KW - Hereditary Hemorrhagic Telangiectasia
UR - https://www.scopus.com/pages/publications/70349783755
U2 - 10.1016/j.ydbio.2009.08.016
DO - 10.1016/j.ydbio.2009.08.016
M3 - Article
C2 - 19703439
AN - SCOPUS:70349783755
SN - 0012-1606
VL - 335
SP - 66
EP - 77
JO - Developmental Biology
JF - Developmental Biology
IS - 1
ER -